Active Ingredient (In Each Immediate-Release Tablet)
Guaifenesin 200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Guaifenesin (NDC 0904-5154). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each immediate-release tablet), purpose, uses, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 200 mg
Expectorant
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
cough persists more than 7 days, tends to recur, or is accompanied by a fever, rash, or persistent headache. These could be signs of a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years and over | 1 to 2 tablets every 4 hours |
| children 6 to under 12 years | ½ to 1 tablet every 4 hours |
| children under 6 years | ask a doctor |
FD&C red #40 aluminum lake, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, silicon dioxide, sodium starch glycolate, stearic acid
1-800-426-9391
* Please review the disclaimer below.